Paul A Voziyan

Biostratum, Inc.

$2,189,015

Attributed

$3,104,629

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $457.8K · FY2005–20

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$3,104,629 · 3

By mechanism

R01$3,004,629 · 2

R41$100,000 · 1

Top collaborators

Billy Gerald Hudson4 shared

Others in their field

Top investigators on “Extracellular Matrix”

Valerie Marie Weaver · University Of California, San Francisco$23,238,959
Naftali Kaminski · Yale University$23,053,857
Kristiina Vuori · Burnham Institute For Medical Research$21,402,128
Paul Wesley Noble · Yale University$20,772,493
Martin A. Schwartz · Yale University$19,622,975
Buddy D Ratner · University Of Washington$19,514,039

Research focus

Extracellular MatrixDiabetic NephropathyGlucosePodocytePreventGlomerular Basement MembranePyridoxamineLaboratoriesPathogenesisNovel TherapeuticsKidneyComplexCellsIn VivoKidney DiseasesIn VitroDiabetes MellitusDiabeticEnd Stage Renal FailurePathway InteractionsModificationMolecularEnzymesCollagen Type Iv